Roles of mTOR in Diabetic Kidney Disease
Open Access
- 22 February 2021
- journal article
- perspective
- Published by MDPI AG in Antioxidants
- Vol. 10 (2), 321
- https://doi.org/10.3390/antiox10020321
Abstract
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease and the number of patients affected is increasing worldwide. Thus, there is a need to establish a new treatment for DKD to improve the renal prognosis of diabetic patients. Recently, it has shown that intracellular metabolic abnormalities are involved in the pathogenesis of DKD. In particular, the activity of mechanistic target of rapamycin complex 1 (mTORC1), a nutrient-sensing signaling molecule, is hyperactivated in various organs of diabetic patients, which suggests the involvement of excessive mTORC1 activation in the pathogenesis of diabetes. In DKD, hyperactivated mTORC1 may be involved in the pathogenesis of podocyte damage, which causes proteinuria, and tubular cell injury that decreases renal function. Therefore, elucidating the role of mTORC1 in DKD and developing new therapeutic agents that suppress mTORC1 hyperactivity may shed new light on DKD treatments in the future.Funding Information
- Japan Society for the Promotion of Science (18K15998)
- Uehara Memorial Foundation (to M.Y-Y)
This publication has 74 references indexed in Scilit:
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from LongevityScience, 2012
- Rapamycin toxicity in MIN6 cells and rat and human islets is mediated by the inhibition of mTOR complex 2 (mTORC2)Diabetologia, 2012
- Nutrient Sensing, Autophagy, and Diabetic NephropathyDiabetes, 2011
- Role of mTOR in podocyte function and diabetic nephropathy in humans and miceJCI Insight, 2011
- mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in miceJCI Insight, 2011
- TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1American Journal of Physiology-Renal Physiology, 2010
- Network organization of the human autophagy systemNature, 2010
- Selective degradation of mitochondria by mitophagyArchives of Biochemistry and Biophysics, 2007
- Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitiveNature, 2004